China Universal Asset Management Company’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$306K	Buy	3,978 +318	+9%	+$24.8K	0.02%	313
2025 Q4	$289K	Sell	3,660 -142	-4%	-$12.3K	0.02%	312
2025 Q3	$348K	Sell	3,802 -547	-13%	-$44.6K	0.03%	281
2025 Q2	$284K	Sell	4,349 -16	-0.4%	-$1.04K	0.03%	283
2025 Q1	$292K	Sell	4,365 -92	-2%	-$5.5K	0.03%	286
2024 Q4	$246K	Buy	4,457 +412	+10%	+$23.7K	0.02%	313
2024 Q3	$241K	Buy	4,045 +1,582	+64%	+$96.5K	0.03%	282
2024 Q2	$157K	Sell	2,463 -1,570	-39%	-$102K	0.02%	268
2024 Q1	$279K	Buy	4,033 +1,666	+70%	+$101K	0.04%	250
2023 Q4	$131K	Buy	2,367 +1,854	+361%	+$102K	0.03%	251
2023 Q3	$29.8K	Buy	513 +248	+94%	+$14.3K	0.01%	268
2023 Q2	$14.3K	Buy	265 +29	+12%	+$1.28K	﹤0.01%	295
2023 Q1	$9.37K	Buy	236 +58	+33%	+$2.45K	﹤0.01%	299
2022 Q4	$7.16K	Buy	+178	New	+$6.69K	﹤0.01%	259